Abstracts (HTML) List of Authors

Salat, A

Erste klinische Ergebnisse der dualen hypothermen ex vivo Leberperfusion vor Lebertransplantation

Sandborn, WJ

Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFI
Efficacy and Safety of Ustekinumab as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI

Sands, BE

Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFI
Efficacy and Safety of Ustekinumab as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI
Sustained Remission in Patients with Moderate to Severe Ulcerative Colitis: Results from the Phase 3 UNIFI Maintenance Study

Sangineto, M

Alpha 1 antitrypsin ameliorates experimental alcoholic liver disease and determines patient outcome

Scarlini, S

The Natural History of Ferroportin Disease – First Results of the International, Multicenter non-HFE Registry

Schaefer, B

A cellular disease model for autosomal dominant ferroportin gene mutations
Low serum ceruloplasmin concentration is common in patients with cirrhosis and a MELD independent predictor of liver transplantation or death
The Natural History of Ferroportin Disease – First Results of the International, Multicenter non-HFE Registry

Schäfer, B

Epidemiologische Modellierung der Häufigkeit und Diagnoserate der Hämochromatose in Tirol
Diagnostic and prognostic accuracy of fibroscan and FIB-4 in hyperferritinemia and hemochromatosis
High pre-test likelihood for non-HFE mutations through full exome sequencing in patients with hepatic iron overload
Alpha 1 antitrypsin ameliorates experimental alcoholic liver disease and determines patient outcome

Scharnagl, H

Loss of bile salt export pump (Bsep/Abcb11) aggravates lipopolysaccharide induced hepatic inflammation in mice
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through anti-inflammatory bile acid composition and signaling

Scheiner, B

Prevalence of non-alcoholic fatty liver disease (NAFLD) among HIV+ individuals in Vienna
Reliability criteria for controlled attenuation parameter (CAP) for assessing hepatic steatosis using transient elastography
Prevalence of and risk factors for anemia in patients with advanced chronic liver disease
Impact of farnesoid X receptor (FXR) polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort
Intraperitoneal activation of the coagulation system via tissue factor-exposing extracellular vesicles and enhanced fibrinolysis in patients with advanced chronic liver disease and ascites
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
The impact of ABO blood type on VWF and factor VIII levels and the prevalence of portal vein thrombosis in patients with advanced chronic liver disease

Schindler, K

Liver Fibrosis stage at baseline predicts outcome of metabolic surgery

Schlattl, M

Lymphozytäre Ösophagitis – Wenn nicht runter geht, was runter soll

Schleischitz, A

Experience with obeticholic acid in patients with primary biliary cholangitis – multicentric Austrian analysis

Schmidbauer, C

Prevalence of non-alcoholic fatty liver disease (NAFLD) among HIV+ individuals in Vienna
Interim results of an ongoing Project to eliminate chronic hepatitis C in People who inject drugs (PWID) with ongoing intravenous drug use and a high risk of non-adherence to direct-acting antivirals (DAA) in Vienna
HCV-Scenario over the last decade at the Medical University Vienna: 6023 viremic HCV(+) patients identified with an 'overestimated' number of 3499 patients potentially left to cure

Schmidbauer, V

Prevalence of non-alcoholic fatty liver disease (NAFLD) among HIV+ individuals in Vienna

Schmiderer, A

Liver Metastasis in solitary fibrous tumors (Hemangioperizytoma) – A case series
Gemcitabine related pneumonitis (GRP) in patients with pancreatic ductal adenocarcinoma (PDAC) – A case series
Malignant peritoneal Mesothelioma: prolonged unexplained CRP" – A case series
Calprotectin versus Lipocalin 2 bei chronisch entzündlichen Darmerkrankungen

Schmidt, R

HCV-Scenario over the last decade at the Medical University Vienna: 6023 viremic HCV(+) patients identified with an 'overestimated' number of 3499 patients potentially left to cure
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension

Schneeberger, S

Is bile leakage after hepatic resection associated with impaired long-term survival?
Risk factors for primary poor function in liver transplantation: a retrospective single centre analysis

Schoder, M

Transjugular intrahepatic portosystemic shunt implantation improves renal function in patients with ascites

Schoeniger-Hekele, M

Learning curve of a modified technique of peroral endoscopic myotomy (POEM) – analysis of safety and efficacy in 9 consecutive patients with follow-up

Schöfl, R

Hot Axios® Duodenojejunostomie bei Ikterus
Experience with obeticholic acid in patients with primary biliary cholangitis – multicentric Austrian analysis

Schönherr, S

The Natural History of Ferroportin Disease – First Results of the International, Multicenter non-HFE Registry

Schubert, R

Interim results of an ongoing Project to eliminate chronic hepatitis C in People who inject drugs (PWID) with ongoing intravenous drug use and a high risk of non-adherence to direct-acting antivirals (DAA) in Vienna

Schulze, K

PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort

Schütz, A

Interim results of an ongoing Project to eliminate chronic hepatitis C in People who inject drugs (PWID) with ongoing intravenous drug use and a high risk of non-adherence to direct-acting antivirals (DAA) in Vienna

Schwabegger, C

Selektive Effekte unterschiedlicher Janus Kinase Inhibitoren auf spezifische intestinale Zellpopulationen

Schwabl, P

Prevalence of non-alcoholic fatty liver disease (NAFLD) among HIV+ individuals in Vienna
Point shear wave elastography by ElastPQ accurately stages hepatic fibrosis in patients with NAFLD: A prospective, multicentric study
Reliability criteria for controlled attenuation parameter (CAP) for assessing hepatic steatosis using transient elastography
Impact of farnesoid X receptor (FXR) polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort
Transjugular intrahepatic portosystemic shunt implantation improves renal function in patients with ascites
Intraperitoneal activation of the coagulation system via tissue factor-exposing extracellular vesicles and enhanced fibrinolysis in patients with advanced chronic liver disease and ascites
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension

Schwanke, C

Interim results of an ongoing Project to eliminate chronic hepatitis C in People who inject drugs (PWID) with ongoing intravenous drug use and a high risk of non-adherence to direct-acting antivirals (DAA) in Vienna

Schwarzer, R

The value of different CT-based methods for diagnosing sarcopenia and predicting mortality in patients with cirrhosis

Schwärzler, J

Lipid peroxidation of polyunsaturated fatty acids triggers a pro-inflammatory cytokine response in intestinal epithelial cells
Western-diet-derived arachidonic acid induces epithelial ferroptosis which is a feature of Crohn's disease
Polyunsaturated fatty acids fuel intestinal inflammation in GPX4 deficient hosts

Seidl, M

HPV-assoziierte, ausgedehnte, hochgradige intraepitheliale Neoplasie (HG-IEN) des Ösophagus – ein Fallbericht

Semmler, G

Functional Liver Imaging Score derived from gadoxetic acid-enhanced MRI predicts outcomes in patients with chronic liver disease
Reliability criteria for controlled attenuation parameter (CAP) for assessing hepatic steatosis using transient elastography
Prevalence of and risk factors for anemia in patients with advanced chronic liver disease
Impact of farnesoid X receptor (FXR) polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension

Severgnini, L

Eradication of HCV Infection in Vorarlberg with DAA Therapy. Data about the period between 2015 and 2019

Siebert, F

Real World Assessment of Biological Treatment of Inflammatory Bowel Disease at an Austrian Referral Centre: The ULTIMATE Study

Sieghart, W

Learning curve of a modified technique of peroral endoscopic myotomy (POEM) – analysis of safety and efficacy in 9 consecutive patients with follow-up
PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort

Silberhumer, G

Erste klinische Ergebnisse der dualen hypothermen ex vivo Leberperfusion vor Lebertransplantation

Silbert-Wagner, D

Does the gut microbiome affect intestinal steroidogenesis?

Simbrunner, B

Prevalence of non-alcoholic fatty liver disease (NAFLD) among HIV+ individuals in Vienna
Point shear wave elastography by ElastPQ accurately stages hepatic fibrosis in patients with NAFLD: A prospective, multicentric study
Functional Liver Imaging Score derived from gadoxetic acid-enhanced MRI predicts outcomes in patients with chronic liver disease
Impact of farnesoid X receptor (FXR) polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
HCV-Scenario over the last decade at the Medical University Vienna: 6023 viremic HCV(+) patients identified with an 'overestimated' number of 3499 patients potentially left to cure

Sirlin, C

Functional Liver Imaging Score derived from gadoxetic acid-enhanced MRI predicts outcomes in patients with chronic liver disease

Soliman, T

Erste klinische Ergebnisse der dualen hypothermen ex vivo Leberperfusion vor Lebertransplantation

Sommer, J

Does the gut microbiome affect intestinal steroidogenesis?

Spindelböck, W

Osteoporose bei sekundär sklerosierenden Cholangitis nach kritischer Erkrankung
The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis

Spindelboeck, W

Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment

Stadlbauer, V

Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment
The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis
A novel score to predict outcome after transjugular intrahepatic portosystemic shunt for refractory ascites (TAS score)

Stadlbauer-Köllner, V

Osteoporose bei sekundär sklerosierenden Cholangitis nach kritischer Erkrankung

Stahlmann, M

Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through anti-inflammatory bile acid composition and signaling

Stättermayer, A

Prospective evaluation for gastrointestinal bleedings at the University Hospital St. Pölten – one year of follow-up
The HSD17B13:TA (rs72613567) splice variant protects against severity of non-alcoholic fatty liver disease but not fibrosis
Prospective evaluation of blood transfusion management in patients with gastrointestinal bleedings at the University Hospital St. Pölten

Stättermayer, AF

Reliability criteria for controlled attenuation parameter (CAP) for assessing hepatic steatosis using transient elastography
Impact of farnesoid X receptor (FXR) polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension

Stättermayer, M

Prospective evaluation for gastrointestinal bleedings at the University Hospital St. Pölten – one year of follow-up
Prospective evaluation of blood transfusion management in patients with gastrointestinal bleedings at the University Hospital St. Pölten
AUSTROBAND: A prospective register of cirrhotic patients with acute variceal bleeding at the UK Sankt Pölten, an update

Stättner, S

Back pain in a locally advanced pNET with hepatic metastases – a rare case with an unusual secondary diagnosis
Is bile leakage after hepatic resection associated with impaired long-term survival?
Sex differences in disease presentation, surgical and oncological outcome of hepatic resection for primary and metastatic liver tumours

Stauber, R

Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment
Health Related Quality of Life and Healthcare Resource Utilization in chronic HCV patients under the Glecaprevir/Pibrentasvir Regimen: Interim-Analysis of the Austrian CONFIRMATION Study
The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis

Staufer, K

The HSD17B13:TA (rs72613567) splice variant protects against severity of non-alcoholic fatty liver disease but not fibrosis

Steidl, K

Real World Assessment of Biological Treatment of Inflammatory Bowel Disease at an Austrian Referral Centre: The ULTIMATE Study

Steiner, P

Akut-ulzerierende, schwere Autoimmunenteropathie des Jejunums: eine Fallserie

Stiegler, P

Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment
The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis

Stiendl, G

Lymphozytäre Ösophagitis – Wenn nicht runter geht, was runter soll

Stift, J

Reliability criteria for controlled attenuation parameter (CAP) for assessing hepatic steatosis using transient elastography
The HSD17B13:TA (rs72613567) splice variant protects against severity of non-alcoholic fatty liver disease but not fibrosis

Stojakovic, T

Loss of bile salt export pump (Bsep/Abcb11) aggravates lipopolysaccharide induced hepatic inflammation in mice
Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through anti-inflammatory bile acid composition and signaling

Strasser, M

AMA-positives without PBC and healthy subjects have similar bile acid profiles but are different from PBC patients

Strawn, D

Molecular Response to Ustekinumab in Moderate-to-severe Ulcerative Colitis by Serum Protein and Biopsy Gene Expression Analysis: Results from the UNIFI Phase 3 Induction Study

Strebinger, G

Biochemical liver tests reflect the genetic risk for fatty liver with increasing body weight but not with alcohol consumption

Streit, A

Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment

Stremnitzer, C

Health Related Quality of Life and Healthcare Resource Utilization in chronic HCV patients under the Glecaprevir/Pibrentasvir Regimen: Interim-Analysis of the Austrian CONFIRMATION Study

Stuppner, H

Auswirkung von PHGG auf Zusammensetzung und Funktion des intestinalen Mikrobioms – Ergebnisse der PAGODA Studie

Sturm, S

Auswirkung von PHGG auf Zusammensetzung und Funktion des intestinalen Mikrobioms – Ergebnisse der PAGODA Studie

Szapary, P

Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFI
Efficacy and Safety of Ustekinumab as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI
Sustained Remission in Patients with Moderate to Severe Ulcerative Colitis: Results from the Phase 3 UNIFI Maintenance Study

Szymanska, A

City or landside area: Do participation rates of quality ensured screening colonoscopy differ?
Influence of moon phases on bowel preparation quality in a screening colonoscopy collective